Theme |
IPMT ; Intraductal Papillary-Mucinous Tumor |
Title |
Outcome After Surgical Resection of Intraductal Papillary-Mucinous Neoplasms of the Pancreas |
Author |
Manabu Takano |
Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine |
Author |
Tomoki Ebata |
Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine |
Author |
Masato Nagino |
Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine |
Author |
Toshiyuki Arai |
Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine |
Author |
Hideki Nishio |
Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine |
Author |
Yuji Nimura |
Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine |
[ Summary ] |
It is generally accepted that the prognosis for intraductal papillary-mucinous neoplasms (IPMN) of the pancreas is fairly good compared with that for pancreatic ductal carcinoma. However, the precise outcome is not easily determined, because the prognosis includes various stages and histological grades of malignancy. Recently, the risk of recurrence from a remnant pancreas and nonpancreatic neoplasms associated with IPMN has been shown to have a relationship to multicentric development of carcinoma. In post operative follow ups on IPMN patients, not only the histological grade of malignancy, but also the possible existence of multiple carcinomas should be considered. |